Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffrey A Tomalka

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Current Opinion in Virology|December 13, 2021
Translating known drivers of COVID-19 disease severity to design better SARS-CoV-2 vaccinesAdam N Pelletier, Rafick P Sekaly, Jeffrey A Tomalka
Cellular & Molecular Immunology|July 5, 2016
Sam68 is a regulator of Toll-like receptor signalingJeffrey A Tomalka, Tristan J de Jesus, Parameswaran Ramakrishnan
Trends in Immunology|July 30, 2022
Innate antiviral immunity: how prior exposures can guide future responsesJeffrey A Tomalka, Mehul S Suthar, Michael S Diamond, et al.
Nature Immunology|February 25, 2022
Fighting the SARS-CoV-2 pandemic requires a global approach to understanding the heterogeneity of vaccine responsesJeffrey A Tomalka, Mehul S Suthar, Steven G Deeks, et al.
Diabetes|May 25, 2016
Deficiency of Nuclear Factor-κB c-Rel Accelerates the Development of Autoimmune Diabetes in NOD MiceParameswaran Ramakrishnan, Mary A Yui, Jeffrey A Tomalka, et al.
Glycobiology|January 14, 2021
Negative regulation of FOXP3 expression by c-Rel O-GlcNAcylationTristan J de Jesus, Jeffrey A Tomalka, Joshua T Centore, et al.
Plos One|March 3, 2025
Pharmacometabolomics in TB meningitis-Understanding the pharmacokinetic, metabolic, and immune factors associated with anti-TB drug concentrations in cerebrospinal fluidJeffrey M Collins, Maia Kipiani, Yutong Jin, et al.
Medrxiv : the Preprint Server for Health Sciences|January 3, 2024
Pharmacometabolomics in TB Meningitis - understanding the pharmacokinetic, metabolic, and immune factors associated with anti-TB drug concentrations in cerebrospinal fluidJeffrey M Collins, Maia Kipiani, Yutong Jin, et al.
Biorxiv : the Preprint Server for Biology|July 16, 2025
A combination TLR7/8 and RIG-I agonist adjuvant reverts asthmatic allergic sensitization and prevents aggravated influenza infection in OVA-sensitized miceJuan García-Bernalt Diego, Eleanor Burgess, Lauren A Chang, et al.
Biorxiv : the Preprint Server for Biology|February 12, 2026
Interleukin-6 restricts pre-thymic T cell lineage commitment of progenitors driving loss of SIV controlSaleem Anwar, Naseem Sadek, Christian Michel Beusch, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Current Opinion in Virology|December 13, 2021
Translating known drivers of COVID-19 disease severity to design better SARS-CoV-2 vaccinesAdam N Pelletier, Rafick P Sekaly, Jeffrey A Tomalka
Cellular & Molecular Immunology|July 5, 2016
Sam68 is a regulator of Toll-like receptor signalingJeffrey A Tomalka, Tristan J de Jesus, Parameswaran Ramakrishnan
Trends in Immunology|July 30, 2022
Innate antiviral immunity: how prior exposures can guide future responsesJeffrey A Tomalka, Mehul S Suthar, Michael S Diamond, et al.
Nature Immunology|February 25, 2022
Fighting the SARS-CoV-2 pandemic requires a global approach to understanding the heterogeneity of vaccine responsesJeffrey A Tomalka, Mehul S Suthar, Steven G Deeks, et al.
Diabetes|May 25, 2016
Deficiency of Nuclear Factor-κB c-Rel Accelerates the Development of Autoimmune Diabetes in NOD MiceParameswaran Ramakrishnan, Mary A Yui, Jeffrey A Tomalka, et al.
Glycobiology|January 14, 2021
Negative regulation of FOXP3 expression by c-Rel O-GlcNAcylationTristan J de Jesus, Jeffrey A Tomalka, Joshua T Centore, et al.
Plos One|March 3, 2025
Pharmacometabolomics in TB meningitis-Understanding the pharmacokinetic, metabolic, and immune factors associated with anti-TB drug concentrations in cerebrospinal fluidJeffrey M Collins, Maia Kipiani, Yutong Jin, et al.
Medrxiv : the Preprint Server for Health Sciences|January 3, 2024
Pharmacometabolomics in TB Meningitis - understanding the pharmacokinetic, metabolic, and immune factors associated with anti-TB drug concentrations in cerebrospinal fluidJeffrey M Collins, Maia Kipiani, Yutong Jin, et al.
Biorxiv : the Preprint Server for Biology|July 16, 2025
A combination TLR7/8 and RIG-I agonist adjuvant reverts asthmatic allergic sensitization and prevents aggravated influenza infection in OVA-sensitized miceJuan García-Bernalt Diego, Eleanor Burgess, Lauren A Chang, et al.
Biorxiv : the Preprint Server for Biology|February 12, 2026
Interleukin-6 restricts pre-thymic T cell lineage commitment of progenitors driving loss of SIV controlSaleem Anwar, Naseem Sadek, Christian Michel Beusch, et al.
Pageof 2